Anticholinergic medications
PreclinicalSmall molecule
Anticholinergic medications is one of 8 small molecule programs targeting Urgency Urinary Incontinence. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
12 competitors in Urgency Urinary Incontinence
#DrugCompanyPhaseTrials
1Vesicare
AstellasApproved
Myrbetriq
AstellasApproved
Oxytrol
WWim Janssens
Approved
Sanctura Xr
VVitae Pharmaceuticals Inc., an Allergan affiliate
Approved
Onabotulinumtoxina 100 UNT
SStanford University
Approved
Beta3-Agonists, Adrenergic
MMansoura University
Approved
Botox
RRevance Therapeutics, Inc.
Preclinical
Anticholinergic medications
UUniversity of New Mexico
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Anticholinergic medications. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of New Mexico